Logo image of AIFF

FIREFLY NEUROSCIENCE INC (AIFF) Stock Fundamental Analysis

NASDAQ:AIFF - US3179701012 - Common Stock

2.67 USD
-0.03 (-1.11%)
Last: 9/3/2025, 8:00:00 PM
2.64 USD
-0.03 (-1.12%)
After Hours: 9/3/2025, 8:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIFF. AIFF was compared to 35 industry peers in the Health Care Technology industry. The financial health of AIFF is average, but there are quite some concerns on its profitability. AIFF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AIFF had negative earnings in the past year.
AIFF had a negative operating cash flow in the past year.
AIFF had negative earnings in 4 of the past 5 years.
AIFF had negative operating cash flow in 4 of the past 5 years.
AIFF Yearly Net Income VS EBIT VS OCF VS FCFAIFF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

AIFF has a worse Return On Assets (-182.40%) than 85.71% of its industry peers.
AIFF's Return On Equity of -225.18% is on the low side compared to the rest of the industry. AIFF is outperformed by 74.29% of its industry peers.
Industry RankSector Rank
ROA -182.4%
ROE -225.18%
ROIC N/A
ROA(3y)-164.93%
ROA(5y)-97.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AIFF Yearly ROA, ROE, ROICAIFF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AIFF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AIFF Yearly Profit, Operating, Gross MarginsAIFF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

6

2. Health

2.1 Basic Checks

AIFF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIFF has more shares outstanding
Compared to 5 years ago, AIFF has more shares outstanding
Compared to 1 year ago, AIFF has a worse debt to assets ratio.
AIFF Yearly Shares OutstandingAIFF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AIFF Yearly Total Debt VS Total AssetsAIFF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -4.23, we must say that AIFF is in the distress zone and has some risk of bankruptcy.
AIFF's Altman-Z score of -4.23 is on the low side compared to the rest of the industry. AIFF is outperformed by 77.14% of its industry peers.
There is no outstanding debt for AIFF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.23
ROIC/WACCN/A
WACC9.95%
AIFF Yearly LT Debt VS Equity VS FCFAIFF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

AIFF has a Current Ratio of 2.69. This indicates that AIFF is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AIFF (2.69) is better than 62.86% of its industry peers.
A Quick Ratio of 2.65 indicates that AIFF has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.65, AIFF is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.65
AIFF Yearly Current Assets VS Current LiabilitesAIFF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AIFF have decreased strongly by -59.54% in the last year.
The Revenue for AIFF has decreased by -92.54% in the past year. This is quite bad
Measured over the past years, AIFF shows a very negative growth in Revenue. The Revenue has been decreasing by -59.70% on average per year.
EPS 1Y (TTM)-59.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.86%
Revenue 1Y (TTM)-92.54%
Revenue growth 3Y-80.7%
Revenue growth 5Y-59.7%
Sales Q2Q%1259.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AIFF Yearly Revenue VS EstimatesAIFF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIFF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIFF Price Earnings VS Forward Price EarningsAIFF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIFF Per share dataAIFF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIFF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIREFLY NEUROSCIENCE INC

NASDAQ:AIFF (9/3/2025, 8:00:00 PM)

After market: 2.64 -0.03 (-1.12%)

2.67

-0.03 (-1.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.24%
Inst Owner Change46.1%
Ins Owners15.32%
Ins Owner Change0%
Market Cap35.75M
AnalystsN/A
Price TargetN/A
Short Float %10.5%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 83.53
P/FCF N/A
P/OCF N/A
P/B 2.95
P/tB 6.13
EV/EBITDA N/A
EPS(TTM)-2.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0.03
BVpS0.9
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -182.4%
ROE -225.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-164.93%
ROA(5y)-97.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 2.65
Altman-Z -4.23
F-Score3
WACC9.95%
ROIC/WACCN/A
Cap/Depr(3y)218.97%
Cap/Depr(5y)257.21%
Cap/Sales(3y)129.58%
Cap/Sales(5y)77.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-92.54%
Revenue growth 3Y-80.7%
Revenue growth 5Y-59.7%
Sales Q2Q%1259.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-133.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.68%
OCF growth 3YN/A
OCF growth 5YN/A